Clinical Trial Update: Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate the combination of fludarabine and cytarabine in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Fludarabine (Fludarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, AML | Phase 2 | Status: COMPLETED | Results posted: 2013-12-03